The present study aimed to investigate the relationship between airflow limitation (AL) severity and comorbidities in comprehensive health examination.
This cross-sectional study included 6661 men and 6044 women aged 40–89 who underwent a lung function test during medical checkups. AL was defined as forced expiratory volume in 1 s/forced vital capacity of < 0.7. Logistic regression analysis was used to assess the association between AL severity and the presence of comorbidities.
When compared with the normal lung function group, subjects with AL had a higher prevalence of lung cancer (odd ratio (OR) 9.88, 95% confidence interval (CI) 3.88–25.14) in men, hypertension (OR 1.63, 95% CI 1.26–2.10) in women, diabetes and hyperglycemia (OR 1.23, 95% CI 1.02–1.49 in men, OR 1.61, 95% CI 1.18–2.20 in women) in men and women after adjusting for potential confounders. In men, lung cancer and MetS (the Joint Interim Statement: JIS) were significantly associated with moderate-to-very severe AL after adjustment. In women, hypertension, diabetes and hyperglycemia, MetS (JIS), and MetS (the Japanese Committee of the Criteria for MetS: JCCMS) were significantly associated with mild AL after adjustment. Hypertension was significantly associated with moderate-to-very severe AL after adjustment in women.
Significant relationships were found between AL severity and the presence of comorbid lung cancer in men, hypertension in women, diabetes and hyperglycemia, and MetS in men and women. Knowledge of comorbidities associated with AL should be widely publicized to raise the awareness of chronic obstructive pulmonary disease (COPD).
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, Updated 2015. http://goldcopd.org/. Accessed 8 Aug 2016.
World Health Organization (WHO). The Top 10 Causes of Death Fact Sheet No 310. 2014. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/. Accessed 28 May 2015.
Gershon AS, Mecredy GC, Guan J, Victor JC, Goldstein R, To T. Quantifying comorbidity in individuals with COPD: a population study. Eur Respir J. 2015;45:14–7. CrossRef
Japanese Respiratory Society. Reference values for spirometry in Japanese adult [Internet]. Available from: http://www.jrs.or.jp/modules/guidelines/index.php?content_id=12. cited 24 Apr 2016. (in Japanese).
Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Athrosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5. CrossRefPubMed
Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and diagnostic criteria for metabolic syndrome. Nippon Naika Gakkai Zasshi. 2005;94:794-809. (in Japanese)
Rabe KF, Wedzicha JA, Wouters EFM, editors. COPD and comorbidity, European Respiratory Monograph. 2013. p. 59.
Hu H, Kurotani K, Sasaki N, Murakami T, Shimizu C, Shimizu M, et al. Optimal waist circumference cut-off points and ability of different metabolic syndrome criteria for predicting diabetes in Japanese men and women: Japan Epidemiology Collaboration on Occupational Health Study. BMC Public Health. 2016;16:220–9. CrossRefPubMedPubMedCentral
- Comorbidities according to airflow limitation severity: data from comprehensive health examination in Japan
- BioMed Central